Further, LRP6 immunoreactivity was more intense in tumor with lymph node metastasis (t-test; with node metastasis N=9, without node metastasis N=19; P=0.0206; Supplementary Table S2 and Figure 4h). The gene discussed is LRP6; the disease is metastatic malignant neoplasm in the lymph nodes.